Hosted on MSN7mon
FDA Expands AstraZeneca's (AZN) Imfinzi Label in Lung CancerAstraZeneca AZN announced that the FDA expanded the label of its blockbuster cancer drug Imfinzi for a fourth indication in lung cancer. The FDA approved Imfinzi in combination with platinum-based ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback